Antitumor activity of nutlin-3 in neuroblastoma with wild-type p53
Tuesday, November 10, 2009 - 18:49
in Health & Medicine
The small-molecule inhibitor nutlin-3 may be a viable treatment option for neuroblastoma patients with wild-type p53 activity, according to a new study published online November 10 in the Journal of the National Cancer Institute.